Structure, Function and Inhibition of Human O-GlcNAc Transferase
人 O-GlcNAc 转移酶的结构、功能和抑制
基本信息
- 批准号:8234495
- 负责人:
- 金额:$ 53.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAttenuatedBindingBiochemicalBiologicalCell ExtractsCell divisionCell physiologyCellsCommunitiesComplexComplications of Diabetes MellitusCysteineDevelopmentDiphosphatesDiseaseElementsEnzymesFamilyFoundationsGluconeogenesisGlycopeptidesGoalsHandHealthHumanInhibitory Concentration 50LaboratoriesLeadLightLinkLysineMalignant NeoplasmsMediatingMethodsModificationMolecularNutrientO-GlcNAc transferasePathologyPathway interactionsPatternPeptidesPlayPost-Translational Protein ProcessingProcessProtein MicrochipsProtein Profiling MicroarraysProteinsProteomeQuinolonesResearchRoleStress Response SignalingStructureStructure-Activity RelationshipSulfonamidesWorkanalogbasecrosslinkdesignenzyme structureenzyme substrateglucose metabolismglycosylationimprovedinhibitor/antagonistinsulin signalinginterestmutantnovelprotein protein interactionresearch studysmall moleculesugartherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): O-GlcNAc transferase (OGT) is an essential mammalian enzyme that catalyzes a unique post-translational modification, O-GlcNAcylation. O-GlcNAcylation has been shown to modulate insulin signaling, gluconeogenesis, and other pathways connected to glucose metabolism. Hyper-O-GlcNAcylation leads to widespread transcriptional changes and has been linked to diabetic complications, cancer, and other pathologies. Therefore, it has been suggested that OGT could be a therapeutic target. A better understanding of the structure and function of OGT is critical for dissecting its biological roles, and small molecule inhibitors are widely sought by the scientific community. The goals of this proposal are i) to supply the structural basis for rational experiments to dissect the biochemical and cellular functions of OGT, ii) to provide validated small molecule inhibitors for use as cellular probes of OGT function, and iii) to develop a proteome-wide substrate profiling approach to identify OGT features required for substrate selection.
PUBLIC HEALTH RELEVANCE: O-GlcNAc transferase (OGT) is an essential mammalian enzyme that catalyzes a unique post-translational modification, O-GlcNAcylation. This modification mediates critical cellular processes involved in nutrient signaling, stress responses, and cell division. Aberrant O-GlcNAcylation has been linked to many diseases, and the work proposed here will lead to the development of small molecule inhibitors to probe OGT's biological roles and potential as a therapeutic target.
描述(由申请人提供):O-GlcNAc转移酶(OGT)是一种重要的哺乳动物酶,可催化独特的翻译后修饰,O-GlcNAc酰化。o - glcn酰化已被证明可以调节胰岛素信号、糖异生和其他与葡萄糖代谢相关的途径。超o - glcn酰化导致广泛的转录改变,并与糖尿病并发症、癌症和其他病理有关。因此,有人认为OGT可能是一个治疗靶点。更好地了解OGT的结构和功能对于解剖其生物学作用至关重要,小分子抑制剂被科学界广泛寻求。本提案的目标是i)为合理的实验提供结构基础,以剖析OGT的生化和细胞功能,ii)提供经过验证的小分子抑制剂,用作OGT功能的细胞探针,以及iii)开发一种蛋白质组范围的底物分析方法,以确定底物选择所需的OGT特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suzanne Walker其他文献
Suzanne Walker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suzanne Walker', 18)}}的其他基金
Exploiting membrane targets to overcome antibiotic resistance
利用膜靶标克服抗生素耐药性
- 批准号:
10699952 - 财政年份:2022
- 资助金额:
$ 53.03万 - 项目类别:
Project 2: Targeting Gram-positive Cell Envelope Assembly
项目 2:靶向革兰氏阳性细胞包膜组装
- 批准号:
10699955 - 财政年份:2022
- 资助金额:
$ 53.03万 - 项目类别:
Subproject 1 Compounds and Strategies for Treating MRSA and VRE
子项目 1 治疗 MRSA 和 VRE 的化合物和策略
- 批准号:
9151286 - 财政年份:2016
- 资助金额:
$ 53.03万 - 项目类别:
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics
利用生物技术生产新型磷酸糖脂抗生素
- 批准号:
8633483 - 财政年份:2013
- 资助金额:
$ 53.03万 - 项目类别:
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics
利用生物技术生产新型磷酸糖脂抗生素
- 批准号:
8411474 - 财政年份:2013
- 资助金额:
$ 53.03万 - 项目类别:
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics
利用生物技术生产新型磷酸糖脂抗生素
- 批准号:
8815348 - 财政年份:2013
- 资助金额:
$ 53.03万 - 项目类别:
Defining OGT's Essential Functions to Guide Therapeutic Approaches
定义 OGT 的基本功能以指导治疗方法
- 批准号:
10316265 - 财政年份:2012
- 资助金额:
$ 53.03万 - 项目类别:
Compound and Strategies for Treating MRSA and VRE
治疗 MRSA 和 VRE 的化合物和策略
- 批准号:
8376868 - 财政年份:2012
- 资助金额:
$ 53.03万 - 项目类别:
Defining OGT's Essential Functions to Guide Therapeutic Approaches - EQUIPMENT SUPPLEMENT
定义 OGT 的基本功能以指导治疗方法 - 设备补充
- 批准号:
10386477 - 财政年份:2012
- 资助金额:
$ 53.03万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 53.03万 - 项目类别:
Research Grant














{{item.name}}会员




